Last reviewed · How we verify

NCT04745247: FACEHAND

Stimulate the Face to Improve Tactile Acuity on the Hand

Status unknown NA Last updated 9 February 2021
What this trial tests

NA trial testing RSS in Stroke in 25 participants. Status unknown.

Timeline
1 February 2021
Primary endpoint
1 February 2021
21 February 2023

Quick facts

Lead sponsorHospices Civils de Lyon
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposebasic science
Enrollment25
Start date1 February 2021
Primary completion1 February 2021
Estimated completion21 February 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

Adults 30 to 80, any sex, with Stroke or RSS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a comparative study, to show that the administration of RSS stimulation on the face compared to the administration of strategy Sham stimulation, results in an temporary improvement in the tactile acuity of the hand in patients with tactile acuity impairment of the hand due to stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04745247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing